ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Aegerion pleads guilty to US marketing violations
pharmatimes
September 26, 2017Aegerion Pharmaceuticals will pay $40.1 million to resolve US investigations into marketing and sales of its cholesterol drug Juxtapid, authorities said on Friday.
Pharma Sources Insight January 2025
